Hemp Inc (HEMP)

[worldisfullofDerps]

2020 predictions: Staff changes at FDA, CBD, personalization, and the microbiome

15-Jan-2020 By Stephen Daniells

The year is new and a lot of people are getting out their crystal balls. NutraIngredients-USA is no exception, and here are our top big issues that will impact the dietary supplements industry in this new decade.

4. CBD?
Yes, I held this until number 4 on the list. The dietary supplements industry is worth $45+ billion dollars, and the vast majority of this has nothing whatsoever to do with CBD-containing products. Despite CBD supplements rocketing to the top spot in the natural channel with $52 million in sales?, CBD remains a minor player in the category.

Late last year, the FDA stated that – for the moment – it cannot conclude that CBD (cannabidiol) is generally recognized as safe (GRAS)? for its use in human food, based on a “lack of scientific information supporting the safety of CBD in food”?. The Agency also sent a raft of warning letters, mostly about unacceptable label claims.

This was followed by a wave of potential class actions against CBD companies large and small.

Politicians are pushing hard for clarity and a resolution, and just this week, a new bill proposed the inclusion of CBD under the definition of dietary supplements found in DSHEA?. The bill would not prevent FDA from requiring NDI notifications, enforcing GMP compliance, and other necessary actions. And would this also only be specific to CBD and therefore, would/ could that freeze out opportunities with other cannabinoids?

What's clear is that something needs to happen and soon.

HTTPS://WWW.NUTRAINGREDIENTS-USA.COM/ARTICLE/2020/01/15/2020-PREDICTIONS-STAFF-CHANGES-AT-FDA-CBD-PERSONALIZATION-AND-THE-MICROBIOME